Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PainEase versus AnGel for pain reduction during intravenous cannulation in children
ACTRN12609000796280Phase 3Not yet recruiting
- Sponsor
- Dr Benjamin D'Souza
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Retamol and platelet-rich plasma (2 arms), sponsored by Dr Benjamin D'Souza. Primary endpoint: Pain associated with IV cannulation. Planned start Sep 2009; status: not yet recruiting.
02
Drugs
Retamolplatelet-rich plasma
Beyond the preview
Go deeper on ACTRN12609000796280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000796280.